0
     

Report Added
Report already added
Global Recombinant Proteins Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Global Recombinant Proteins Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Executive Summary

According to GRD Survey data, the global Recombinant Proteins market is estimated at 710 million US$ in 2021 and is expected to reach 1340 million US$ by the end of 2028, growing at a CAGR of 9.4% in the forecast period between 2022 and 2028.

This report studies the Recombinant Proteins market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Recombinant Proteins in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.

Market Snapshot, By Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.

Main Market Players Analyzed in this report, including:
Thermo Fisher Scientific
Sigma Aldrich Company
Reprocell
R&D Systems
ProSpec Tany TechnoGene
PeproTech
Miltenyi Biotec
Merck KGaA
Lonza
GenScript Biotech Corporation
GE Healthcare
Eurogentec (Kaneka Corporation)
BPS Bioscience
Abnova Corporation
Abcam PLC

The study objectives of this report are:
To study and analyze the global Recombinant Proteins market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Recombinant Proteins market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Recombinant Proteins manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Recombinant Proteins market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Recombinant Proteins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Recombinant Proteins are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Recombinant Proteins Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Recombinant Proteins Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Recombinant Proteins

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Recombinant Proteins Sales Channel and Distributors Analysis
3.3.1 Recombinant Proteins Sales Channel
3.3.2 Recombinant Proteins Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Biopharmaceutical Companies
3.4.2 Major Buyers in Academic and Research Institutes
3.5 Recombinant Proteins Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Recombinant Proteins Type Introduction
4.1.1 Hormones
4.1.2 Growth Factors
4.1.3 Cytokines
4.1.4 Plasma Protein Factor
4.1.5 Recombinant Metabolic Enzymes
4.1.6 Immune Checkpoint Regulators
4.1.7 Others
4.1.8 Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.
4.2 Global Recombinant Proteins Sales by Type 2016-2021
4.3 Global Recombinant Proteins Revenue by Type 2016-2021
4.4 Global Recombinant Proteins Price by Type 2016-2021

5 Market Segment: by Application
5.1 Recombinant Proteins Type Introduction
5.1.1 Biopharmaceutical Companies
5.1.2 Academic and Research Institutes
5.1.3 Contract Research Organizations
5.1.3 Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.
5.2 Global Recombinant Proteins Sales by Application 2016-2021
5.3 Global Recombinant Proteins Revenue by Application 2016-2021
5.4 Global Recombinant Proteins Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Recombinant Proteins Market by Region
6.1.1 Global Recombinant Proteins Sales by Regions
6.1.2 Global Recombinant Proteins Revenue by Regions
6.2 North America Recombinant Proteins Market 2016-2021
6.3 Europe Recombinant Proteins Market 2016-2021
6.4 Asia Pacific Recombinant Proteins Market 2016-2021
6.5 South America Recombinant Proteins Market 2016-2021
6.6 Middle East and Africa Recombinant Proteins Market 2016-2021

7 North America
7.1 North America Recombinant Proteins Market by Country 2016-2021
7.1.1 North America Recombinant Proteins Sales by Country
7.1.2 North America Recombinant Proteins Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Recombinant Proteins Market by Country 2016-2021
8.1.1 Europe Recombinant Proteins Sales by Country
8.1.2 Europe Recombinant Proteins Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Recombinant Proteins Market by Country 2016-2021
9.1.1 Asia Pacific Recombinant Proteins Sales by Country
9.1.2 Asia Pacific Recombinant Proteins Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Recombinant Proteins Market by Country 2016-2021
10.1.1 South America Recombinant Proteins Sales by Country
10.1.2 South America Recombinant Proteins Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Recombinant Proteins Market by Country 2016-2021
11.1.1 Middle East and Africa Recombinant Proteins Sales by Country
11.1.2 Middle East and Africa Recombinant Proteins Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Information
12.1.2 Thermo Fisher Scientific Recombinant Proteins Product Portfolio, Specification and Application
12.1.3 Thermo Fisher Scientific Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Thermo Fisher Scientific Key Development
12.2 Sigma Aldrich Company
12.2.1 Sigma Aldrich Company Company Information
12.2.2 Sigma Aldrich Company Recombinant Proteins Product Portfolio, Specification and Application
12.2.3 Sigma Aldrich Company Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sigma Aldrich Company Key Development
12.3 Reprocell
12.3.1 Reprocell Company Information
12.3.2 Reprocell Recombinant Proteins Product Portfolio, Specification and Application
12.3.3 Reprocell Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Reprocell Key Development
12.4 R&D Systems
12.4.1 R&D Systems Company Information
12.4.2 R&D Systems Recombinant Proteins Product Portfolio, Specification and Application
12.4.3 R&D Systems Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 R&D Systems Key Development
12.5 ProSpec Tany TechnoGene
12.5.1 ProSpec Tany TechnoGene Company Information
12.5.2 ProSpec Tany TechnoGene Recombinant Proteins Product Portfolio, Specification and Application
12.5.3 ProSpec Tany TechnoGene Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 ProSpec Tany TechnoGene Key Development
12.6 PeproTech
12.6.1 PeproTech Company Information
12.6.2 PeproTech Recombinant Proteins Product Portfolio, Specification and Application
12.6.3 PeproTech Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 PeproTech Key Development
12.7 Miltenyi Biotec
12.7.1 Miltenyi Biotec Company Information
12.7.2 Miltenyi Biotec Recombinant Proteins Product Portfolio, Specification and Application
12.7.3 Miltenyi Biotec Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 PeproTech Key Development
12.9 Lonza
12.9.1 Lonza Company Information
12.9.2 Lonza Recombinant Proteins Product Portfolio, Specification and Application
12.9.3 Lonza Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Lonza Key Development
12.8 Merck KGaA
12.8.1 Merck KGaA Company Information
12.8.2 Merck KGaA Recombinant Proteins Product Portfolio, Specification and Application
12.8.3 Merck KGaA Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Merck KGaA Key Development
12.11 GE Healthcare
12.11.1 GE Healthcare Company Information
12.11.2 GE Healthcare Recombinant Proteins Product Portfolio, Specification and Application
12.11.3 GE Healthcare Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 GE Healthcare Key Development
12.12 Eurogentec (Kaneka Corporation)
12.12.1 Eurogentec (Kaneka Corporation) Company Information
12.12.2 Eurogentec (Kaneka Corporation) Recombinant Proteins Product Portfolio, Specification and Application
12.12.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Eurogentec (Kaneka Corporation) Key Development
12.13 BPS Bioscience
12.13.1 BPS Bioscience Company Information
12.13.2 BPS Bioscience Recombinant Proteins Product Portfolio, Specification and Application
12.13.3 BPS Bioscience Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 BPS Bioscience Key Development
12.14 Abnova Corporation
12.14.1 Abnova Corporation Company Information
12.14.2 Abnova Corporation Recombinant Proteins Product Portfolio, Specification and Application
12.14.3 Abnova Corporation Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Abnova Corporation Key Development
12.15 Abcam PLC
12.15.1 Abcam PLC Company Information
12.15.2 Abcam PLC Recombinant Proteins Product Portfolio, Specification and Application
12.15.3 Abcam PLC Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Abcam PLC Key Development

13 Global Recombinant Proteins Market Forecast by Region by Type and by Application
13.1 Global Recombinant Proteins Sales, Revenue Forecast 2022-2027
13.2 Global Recombinant Proteins Forecast by Regions
13.2.1 Global Recombinant Proteins Sales Forecast by Region 2022-2027
13.2.2 Global Recombinant Proteins Revenue Forecast by Region 2022-2027
13.3 Global Recombinant Proteins Forecast by Type
13.3.1 Global Recombinant Proteins Sales Forecast by Type 2022-2027
13.3.2 Global Recombinant Proteins Revenue Forecast by Type 2022-2027
13.3.3 Global Recombinant Proteins Price Forecast by Type 2022-2027
13.4 Global Recombinant Proteins Forecast by Application
13.4.1 Global Recombinant Proteins Sales Forecast by Application 2022-2027
13.4.2 Global Recombinant Proteins Revenue Forecast by Application 2022-2027
13.4.3 Global Recombinant Proteins Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Tables

Table 1: Global Recombinant Proteins Production Specifications
Table 2: Drivers in Recombinant Proteins Market
Table 3: Restraints Recombinant Proteins Market
Table 4: Opportunity in Recombinant Proteins Market
Table 5: Comparion of Alternative and Recombinant Proteins
Table 6: Recombinant Proteins Raw Materials Key Suppliers List
Table 7: Recombinant Proteins Distributors List
Table 8: Recombinant Proteins Major Buyers in Biopharmaceutical Companies
Table 9: Recombinant Proteins Major Buyers in Academic and Research Institutes
Table 10: Recombinant Proteins Major Buyers in Contract Research Organizations
Table 11: Global Recombinant Proteins Sales (K Units) by Type 2016-2021
Table 12: Global Recombinant Proteins Sales Market Share by Type 2016-2021
Table 13: Global Recombinant Proteins Revenue (Million USD) by Type 2016-2021
Table 14: Global Recombinant Proteins Revenue Market Share by Type 2016-2021
Table 15: Global Recombinant Proteins Price by Type 2016-2021
Table 16: Global Recombinant Proteins Sales (K Units) by Application 2016-2021
Table 17: Global Recombinant Proteins Sales Market Share by Application 2016-2021
Table 18: Global Recombinant Proteins Revenue (Million USD) by Application 2016-2021
Table 19: Global Recombinant Proteins Revenue Market Share by Application 2016-2021
Table 20: Global Recombinant Proteins Price by Application 2016-2021
Table 21: Global Recombinant Proteins Sales (K Units) by Region 2016-2021
Table 22: Global Recombinant Proteins Sales Market Share by Region 2016-2021
Table 23: Global Recombinant Proteins Revenue (Million USD) by Region 2016-2021
Table 24: Global Recombinant Proteins Revenue Market Share by Region 2016-2021
Table 25: North America Recombinant Proteins Sales (K Units) by Country 2016-2021
Table 26: North America Recombinant Proteins Sales Market Share by Country 2016-2021
Table 27: North America Recombinant Proteins Revenue (Million USD) by Country 2016-2021
Table 28: North America Recombinant Proteins Revenue Market Share by Country 2016-2021)
Table 29: Europe Recombinant Proteins Sales (K Units) by Country 2016-2021
Table 30: Europe Recombinant Proteins Sales Market Share by Country 2016-2021
Table 31: Europe Recombinant Proteins Revenue (Million USD) by Country 2016-2021
Table 32: Europe Recombinant Proteins Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Recombinant Proteins Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Recombinant Proteins Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Recombinant Proteins Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Recombinant Proteins Revenue Market Share by Country 2016-2021)
Table 37: South America Recombinant Proteins Sales (K Units) by Country 2016-2021
Table 38: South America Recombinant Proteins Sales Market Share by Country 2016-2021
Table 39: South America Recombinant Proteins Revenue (Million USD) by Country 2016-2021
Table 40: South America Recombinant Proteins Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Recombinant Proteins Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Recombinant Proteins Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Recombinant Proteins Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Recombinant Proteins Revenue Market Share by Country 2016-2021)
Table 45 Thermo Fisher Scientific Company Information
Table 46 Thermo Fisher Scientific Recombinant Proteins Product Portfolio, Specification and Application
Table 47 Thermo Fisher Scientific Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Sigma Aldrich Company Company Information
Table 49 Sigma Aldrich Company Recombinant Proteins Product Portfolio, Specification and Application
Table 50 Sigma Aldrich Company Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Reprocell Company Information
Table 52 Reprocell Recombinant Proteins Product Portfolio, Specification and Application
Table 53 Reprocell Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 R&D Systems Company Information
Table 55 R&D Systems Recombinant Proteins Product Portfolio, Specification and Application
Table 56 R&D Systems Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 ProSpec Tany TechnoGene Company Information
Table 58 ProSpec Tany TechnoGene Recombinant Proteins Product Portfolio, Specification and Application
Table 59 ProSpec Tany TechnoGene Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 PeproTech Company Information
Table 61 PeproTech Recombinant Proteins Product Portfolio, Specification and Application
Table 62 PeproTech Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Miltenyi Biotec Company Information
Table 64 Miltenyi Biotec Recombinant Proteins Product Portfolio, Specification and Application
Table 65 Miltenyi Biotec Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Merck KGaA Company Information
Table 67 Merck KGaA Recombinant Proteins Product Portfolio, Specification and Application
Table 68 Merck KGaA Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Lonza Company Information
Table 70 Lonza Recombinant Proteins Product Portfolio, Specification and Application
Table 71 Lonza Recombinant Proteins Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Recombinant Proteins Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Recombinant Proteins Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Recombinant Proteins Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Recombinant Proteins Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Recombinant Proteins Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Recombinant Proteins Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Recombinant Proteins Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Recombinant Proteins Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Recombinant Proteins Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Recombinant Proteins Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Recombinant Proteins Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Recombinant Proteins Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Recombinant Proteins Picture
Figure 2: Global Recombinant Proteins Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Recombinant Proteins Supply Chain Analysis
Figure 5: Recombinant Proteins Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Hormones
Figure 7: Product Picture of Growth Factors
Figure 8: Global Recombinant Proteins Sales Market Share by Type, 2020
Figure 9: Global Recombinant Proteins Revenue Market Share by Type, 2020
Figure 10: Recombinant Proteins in Biopharmaceutical Companies
Figure 11: Global Recombinant Proteins Market: Biopharmaceutical Companies 2016-2021
Figure 12: Recombinant Proteins in Academic and Research Institutes
Figure 13: Global Recombinant Proteins Market: Academic and Research Institutes 2016-2021
Figure 14: Global Recombinant Proteins Sales Market Share by Application, 2020
Figure 15: Global Recombinant Proteins Revenue Market Share by Application, 2020
Figure 16: Global Recombinant Proteins Sales Market Share by Region 2016-2021
Figure 17: Global Recombinant Proteins Revenue Market Share by Region 2016-2021
Figure 18: North America Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 19: North America Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 20: Europe Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 21: Europe Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 24: South America Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 25: South America Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 28: North America Recombinant Proteins Sales Market Share by Country, 2020
Figure 29: North America Recombinant Proteins Revenue Market Share by Country, 2020
Figure 30: United States Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 31: United States Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 32: Canada Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 33: Canada Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 35: Mexico Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 36: Europe Recombinant Proteins Sales Market Share by Country, 2020
Figure 37: Europe Recombinant Proteins Revenue Market Share by Country, 2020
Figure 38: Germany Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 39: Germany Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 40: France Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 41: France Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 42: UK Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 43: UK Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 44: Italy Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 45: Italy Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 46: Russia Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 46: Russia Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 47: Spain Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 48: Spain Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Recombinant Proteins Sales Market Share by Country, 2020
Figure 50: Asia Pacific Recombinant Proteins Revenue Market Share by Country, 2020
Figure 51: China Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 52: China Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 53: Japan Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 54: Japan Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 55: Korea Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 56: Korea Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 59: India Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 60: India Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 61: Australia Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 62: Australia Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 63: South America Recombinant Proteins Sales Market Share by Country, 2020
Figure 64: South America Recombinant Proteins Revenue Market Share by Country, 2020
Figure 65: Brazil Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 66: Brazil Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 68: Argentina Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 70: Colombia Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Recombinant Proteins Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Recombinant Proteins Revenue Market Share by Country, 2020
Figure 73: Turkey Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 74: Turkey Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Recombinant Proteins Sales (K Units) Status 2016-2021
Figure 78: South Africa Recombinant Proteins Revenue (Million USD) Status 2016-2021
Figure 79: Thermo Fisher Scientific Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 80: Sigma Aldrich Company Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 81: Reprocell Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 82: R&D Systems Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 83: ProSpec Tany TechnoGene Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 84: PeproTech Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 85: Miltenyi Biotec Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 86: Merck KGaA Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 87: Lonza Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 88: GenScript Biotech Corporation Recombinant Proteins Revenue Market Share Globally (2019-2021)
Figure 89: Global Recombinant Proteins Sales (K Units) Forecast (2022-2027)
Figure 90: Global Recombinant Proteins Sales (K Units) Forecast (2022-2027)

Report Title: Global Recombinant Proteins Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2022 What's Next for Vietnam Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Vietnam Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Venezuela Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Venezuela Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for US Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for US Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Uruguay Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Uruguay Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for United Arab Emirates Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for United Arab Emirates Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Ukraine Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Ukraine Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM